The revival of Phage Therapy to fight Antimicrobial Resistance – Part I: What are the legal implications?

Medicine & Life Sciences

• Phage Therapy 100%
• Bacteriophages 37%
• European Union 18%
• Bacteria 14%
• Anti-Bacterial Agents 14%
• Viruses 10%
• Nuclear Weapons 8%
• Intellectual Property 8%
• National Institute of Allergy and Infectious Diseases (U.S.) 8%
• Public-Private Sector Partnerships 8%
• Research Personnel 7%
• USSR 7%
• Influenza Vaccines 6%
• Gastrointestinal Diseases 5%
• Burns 5%
• Microbial Drug Resistance 5%
• Infections 5%
• Bacterial Infections 5%
• Pharmaceutical Preparations 4%
• Head 3%
• Therapeutics 3%
• Clinical Trials 3%
• Safety 3%